AI Empowers Patients to Navigate Cancer Care
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
An AACR Patient Advocate Forum assembled a panel of experts to discuss how AI tools can help advance cancer...
recent data suggest that there is another potential contender for a biomarker-based FDA approval: a targeted therapeutic called larotrectinib...
Prevention is often said to be more powerful than a cure. With an eye toward thwarting the disease, some...
As spring is a time for flowers to bloom, public education at the American Association for Cancer Research (AACR)...
The American Association for Cancer Research (AACR) wrapped up National Cancer Research Month by inviting a group of 50...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
Today is National “Don’t Fry Day,” an initiative undertaken by the National Council on Skin Cancer Prevention to encourage...
Tuesday marked a milestone for the oncology community: The U.S. Food and Drug Administration (FDA) announced its first approval...
At the end of last week, the U.S. Food and Drug Administration (FDA) approved expanding the use of pembrolizumab...
May is National Cancer Research Month, and for the past 10 years, leaders and members from the American Association...
In recent years, the American Association for Cancer Research (AACR) has expanded its efforts to catalyze advances in cancer...